Ekso Bionics Holdings, Inc. – NASDAQ:EKSO
Ekso Bionics Holdings stock price today
$3.16
+2.51
+386.9%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 14 hours
Ekso Bionics Holdings stock price monthly change
-45.46%
month
Ekso Bionics Holdings stock price quarterly change
-45.46%
quarter
Ekso Bionics Holdings stock price yearly change
-61.14%
year
Ekso Bionics Holdings key metrics
Market Cap | 13.18M |
Enterprise value | 7.84M |
P/E | -1.42 |
EV/Sales | 0.41 |
EV/EBITDA | -0.37 |
Price/Sales | 1.10 |
Price/Book | 0.82 |
PEG ratio | 0.03 |
EPS | -0.97 |
Revenue | 17.91M |
EBITDA | -12.25M |
Income | -14.23M |
Revenue Q/Q | -8.87% |
Revenue Y/Y | 23.81% |
Profit margin | -119.71% |
Oper. margin | -121.53% |
Gross margin | 47.85% |
EBIT margin | -121.53% |
EBITDA margin | -68.43% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEkso Bionics Holdings stock price history
Ekso Bionics Holdings stock forecast
Ekso Bionics Holdings financial statements
Average Price Target
$2
Potential downside: -36.70%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 4.70M | -4.23M | -89.94% |
|---|---|---|---|
| Sep 2023 | 4.60M | -3.36M | -73.04% |
| Dec 2023 | 4.84M | -3.21M | -66.31% |
| Mar 2024 | 3.75M | -3.42M | -91.29% |
| Jun 2023 | 33986000 | 16.17M | 47.6% |
|---|---|---|---|
| Sep 2023 | 31183000 | 15.92M | 51.07% |
| Dec 2023 | 28918000 | 16.31M | 56.41% |
| Mar 2024 | 28957000 | 14.90M | 51.48% |
| Jun 2023 | -2.90M | -55K | 0 |
|---|---|---|---|
| Sep 2023 | -3.35M | -17K | 0 |
| Dec 2023 | -1.58M | -43K | 348K |
| Mar 2024 | -3.46M | -8K | 3.65M |
Ekso Bionics Holdings alternative data
| Aug 2023 | 72 |
|---|---|
| Sep 2023 | 72 |
| Oct 2023 | 72 |
| Nov 2023 | 72 |
| Dec 2023 | 72 |
| Jan 2024 | 72 |
| Feb 2024 | 72 |
| Mar 2024 | 70 |
| Apr 2024 | 70 |
| May 2024 | 70 |
| Jun 2024 | 70 |
| Jul 2024 | 70 |
Ekso Bionics Holdings other data
5.06%
-5.91%
of EKSO is owned by hedge funds
656.06K
-777.66K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2022 | 0 | 10576 |
| May 2023 | 0 | 49095 |
| Aug 2023 | 5500 | 50230 |
| Nov 2023 | 4032 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | LATHAN CORINNA director | Common Stock | 4,032 | $1.24 | $5,004 | ||
Purchase | LATHAN CORINNA director | Common Stock | 5,500 | $0.95 | $5,220 | ||
Sale | DAVIS SCOTT G. officer: President & COO | Common Stock | 37,446 | $1 | $37,296 | ||
Sale | WONG JEROME officer: Chief Financial Officer | Common Stock | 12,784 | $1 | $12,733 | ||
Sale | SHERMAN STEVEN officer: Executiv.. | Common Stock | 45,660 | $1.44 | $65,887 | ||
Sale | JONES JASON C officer: Chief Operating Officer | Common Stock | 3,435 | $1.57 | $5,400 | ||
Option | SHERMAN STEVEN officer: Executiv.. | Restricted Stock Units | 31,198 | N/A | N/A | ||
Sale | SHERMAN STEVEN officer: Executiv.. | Common Stock | 10,576 | $1.28 | $13,495 | ||
Option | SHERMAN STEVEN officer: Executiv.. | Common Stock | 31,198 | N/A | N/A | ||
Option | SHERMAN STEVEN director, officer.. | Restricted Stock Units | 15,599 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q1 2024 29 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 4 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 26 Oct 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 27 Jul 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. William R. Shaw (1974) Chief Commercial Officer | $402,140 |
| Mr. Jack Peurach (1966) Pres, Chief Executive Officer & Director | $366,720 |
| Mr. John F. Glenn (1962) Chief Financial Officer & Sec. | $332,000 |
| Mr. Steven A. Sherman (1946) Executive Chairman | $100,000 |
-
What's the price of Ekso Bionics Holdings stock today?
One share of Ekso Bionics Holdings stock can currently be purchased for approximately $3.16.
-
When is Ekso Bionics Holdings's next earnings date?
Unfortunately, Ekso Bionics Holdings's (EKSO) next earnings date is currently unknown.
-
Does Ekso Bionics Holdings pay dividends?
No, Ekso Bionics Holdings does not pay dividends.
-
How much money does Ekso Bionics Holdings make?
Ekso Bionics Holdings has a market capitalization of 13.18M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 41.57% to 18.28M US dollars.
-
What is Ekso Bionics Holdings's stock symbol?
Ekso Bionics Holdings, Inc. is traded on the NASDAQ under the ticker symbol "EKSO".
-
What is Ekso Bionics Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Ekso Bionics Holdings?
Shares of Ekso Bionics Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Ekso Bionics Holdings's key executives?
Ekso Bionics Holdings's management team includes the following people:
- Mr. William R. Shaw Chief Commercial Officer(age: 51, pay: $402,140)
- Mr. Jack Peurach Pres, Chief Executive Officer & Director(age: 59, pay: $366,720)
- Mr. John F. Glenn Chief Financial Officer & Sec.(age: 63, pay: $332,000)
- Mr. Steven A. Sherman Executive Chairman(age: 79, pay: $100,000)
-
How many employees does Ekso Bionics Holdings have?
As Jul 2024, Ekso Bionics Holdings employs 70 workers.
-
When Ekso Bionics Holdings went public?
Ekso Bionics Holdings, Inc. is publicly traded company for more then 11 years since IPO on 17 Jan 2014.
-
What is Ekso Bionics Holdings's official website?
The official website for Ekso Bionics Holdings is eksobionics.com.
-
Where are Ekso Bionics Holdings's headquarters?
Ekso Bionics Holdings is headquartered at 1414 Harbour Way South, Richmond, CA.
-
How can i contact Ekso Bionics Holdings?
Ekso Bionics Holdings's mailing address is 1414 Harbour Way South, Richmond, CA and company can be reached via phone at +51 09841761.
-
What is Ekso Bionics Holdings stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Ekso Bionics Holdings in the last 12 months, the avarage price target is $2. The average price target represents a -36.70% change from the last price of $3.16.
Ekso Bionics Holdings company profile:
Ekso Bionics Holdings, Inc.
eksobionics.comExchange:
NASDAQ
Full time employees:
70
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
1414 Harbour Way South
Richmond, CA 94804
Richmond, CA 94804
CIK: 0001549084
ISIN: US2826443010
CUSIP: 282644301
